Chongqing Mas Sci.&Tech.Co.Ltd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Chongqing Mas Sci.&Tech.Co.Ltd şirketinin toplam hissedar öz sermayesi CN¥881.6M ve toplam borcu CN¥159.5M olup, bu da borç-öz sermaye oranını 18.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥1.3B ve CN¥463.0M dir. Chongqing Mas Sci.&Tech.Co.Ltd 'in FAVÖK'ü CN¥66.2M faiz karşılama oranı 97.6 dur. Şirketin CN¥35.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

18.1%

Borç/özkaynak oranı

CN¥159.50m

Borç

Faiz karşılama oranı	97.6x
Nakit	CN¥35.44m
Eşitlik	CN¥881.58m
Toplam yükümlülükler	CN¥463.02m
Toplam varlıklar	CN¥1.34b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Revenues Tell The Story For Chongqing Mas Sci.&Tech.Co.,Ltd. (SZSE:300275) As Its Stock Soars 39%

Oct 08

Chongqing Mas Sci.&Tech.Co.Ltd (SZSE:300275) Shareholders Will Want The ROCE Trajectory To Continue

Jun 08

Why Investors Shouldn't Be Surprised By Chongqing Mas Sci.&Tech.Co.,Ltd.'s (SZSE:300275) 37% Share Price Surge

May 21

If EPS Growth Is Important To You, Chongqing Mas Sci.&Tech.Co.Ltd (SZSE:300275) Presents An Opportunity

Apr 23

Investors Appear Satisfied With Chongqing Mas Sci.&Tech.Co.,Ltd.'s (SZSE:300275) Prospects As Shares Rocket 38%

Mar 06

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 300275 'nin kısa vadeli varlıkları ( CN¥786.8M ) kısa vadeli yükümlülüklerini ( CN¥346.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: 300275 şirketinin kısa vadeli varlıkları ( CN¥786.8M ) uzun vadeli yükümlülüklerini ( CN¥116.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 300275 'nin net borç/öz sermaye oranı ( 14.1% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 300275 şirketinin borç/öz sermaye oranı son 5 yılda 8.8% seviyesinden 18.1% seviyesine yükseldi.

Borç Kapsamı: 300275 'nin borcu işletme nakit akışı ( 10.9% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 300275 'in borcuna ilişkin faiz ödemeleri EBIT ( 97.6 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Chongqing Mas Sci.&Tech.Co.Ltd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.047 (vs CN¥0.023 in 3Q 2023)

Investor sentiment deteriorates as stock falls 19%

Revenues Tell The Story For Chongqing Mas Sci.&Tech.Co.,Ltd. (SZSE:300275) As Its Stock Soars 39%

Chongqing Mas Sci.&Tech.Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Second quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.064 in 2Q 2023)

Chongqing Mas Sci.&Tech.Co.,Ltd. to Report First Half, 2024 Results on Aug 10, 2024

Chongqing Mas Sci.&Tech.Co.Ltd (SZSE:300275) Shareholders Will Want The ROCE Trajectory To Continue

Dividend of CN¥0.023 announced

Chongqing Mas Sci.&Tech.Co.,Ltd. Implements Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024

Why Investors Shouldn't Be Surprised By Chongqing Mas Sci.&Tech.Co.,Ltd.'s (SZSE:300275) 37% Share Price Surge

Investor sentiment improves as stock rises 15%

Chongqing Mas Sci.&Tech.Co.,Ltd. Proposes Final Cash Dividend for the Year 2023

Chongqing Mas Sci.&Tech.Co.,Ltd., Annual General Meeting, May 15, 2024

First quarter 2024 earnings released: EPS: CN¥0.041 (vs CN¥0.03 in 1Q 2023)

If EPS Growth Is Important To You, Chongqing Mas Sci.&Tech.Co.Ltd (SZSE:300275) Presents An Opportunity

Investor sentiment deteriorates as stock falls 18%

Chongqing Mas Sci.&Tech.Co.,Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investors Appear Satisfied With Chongqing Mas Sci.&Tech.Co.,Ltd.'s (SZSE:300275) Prospects As Shares Rocket 38%

Chongqing Mas Sci.&Tech.Co.,Ltd. (SZSE:300275) announces an Equity Buyback for CNY 50 million worth of its shares.

Chongqing Mas Sci.&Tech.Co.,Ltd. (SZSE:300275) announces an Equity Buyback for CNY 50 million worth of its shares.

Investor sentiment deteriorates as stock falls 16%

Chongqing Mas Sci.&Tech.Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.023 (vs CN¥0.022 in 3Q 2022)

Chongqing Mas Sci.&Tech.Co.,Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.064 (vs CN¥0.034 in 2Q 2022)

Chongqing Mas Sci.&Tech.Co.,Ltd. Approves Election of Cheng Yuanwei as an Independent Director

Chongqing Mas Sci.&Tech.Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023

First quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.043 in 1Q 2022)

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.035 (vs CN¥0.029 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.055 (vs CN¥0.045 in 2Q 2021)

Less than half of directors are independent

Chongqing Mas Sci.&Tech. Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 27 May 2022

Chongqing Mas Sci.&Tech. Co., Ltd. Approves Cash Dividend for 2021

Investor sentiment improved over the past week

Chongqing Mas Sci.&Tech. Co., Ltd. Proposes Cash Dividend for 2021

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Chongqing Mas Sci.&Tech. Co., Ltd. Announces Executive Changes

Third quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.033 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.045 (vs CN¥0.052 in 2Q 2020)

Chongqing Mas Sci.&Tech. Co., Ltd. (SZSE:300275) made a proposal to acquire 10% stake in Huayang Communication Technology Co., Ltd. from Xuzhou China University of Mining and Technology Asset Management Co., Ltd. for CNY 16.4 million.

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.031 (vs CN¥0.029 in 1Q 2020)

Chongqing Mas Sci.&Tech. Co., Ltd. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day low: CN¥9.30

New 90-day low: CN¥9.73

New 90-day low: CN¥11.20

New 90-day low: CN¥11.71

Chongqing Mas Sci.&Tech. Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥14.01

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin